Lawrence E. Bullock, Chief Financial Officer at BIOMIMETIC THERAPEUTICS, INC. (BMTI), bought 10,000 shares at $9.00 ($90K) on 2008-03-28, disclosed to the SEC on 2008-04-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BMTI | BUY | 2009-04-01 | $41K | — | Filing → |
| BMTI | BUY | 2006-05-15 | $80K | — | Filing → |